.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Teva
Express Scripts
Daiichi Sankyo
Colorcon
Medtronic
UBS
Fish and Richardson
Dow
Healthtrust

Generated: July 24, 2017

DrugPatentWatch Database Preview

Pharmacia Company Profile

« Back to Dashboard

What is the competitive landscape for PHARMACIA, and when can generic versions of PHARMACIA drugs launch?

PHARMACIA has one hundred and thirty-seven approved drugs.

There are nine US patents protecting PHARMACIA drugs.

There are two hundred and nine patent family members on PHARMACIA drugs in forty-five countries.

Summary for Applicant: Pharmacia

Patents:9
Tradenames:111
Ingredients:86
NDAs:137
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
NEO-DELTA-CORTEF
neomycin sulfate; prednisolone acetate
OINTMENT;OPHTHALMIC061039-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN HYDROCHLORIDE
clindamycin hydrochloride
CAPSULE;ORAL050162-003Apr 14, 1988ABRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
VANTIN
cefpodoxime proxetil
TABLET;ORAL050674-001Aug 7, 1992DISCNYesNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DIDREX
benzphetamine hydrochloride
TABLET;ORAL012427-003Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
CYKLOKAPRON
tranexamic acid
TABLET;ORAL019280-001Dec 30, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Pharmacia

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
HALCION
triazolam
TABLET;ORAL017892-001Nov 15, 1982► Subscribe► Subscribe
Pharmacia And Upjohn
PROSTIN E2
dinoprostone
SUPPOSITORY;VAGINAL017810-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Pharmacia And Upjohn
GLYNASE
glyburide
TABLET;ORAL020051-004Sep 24, 1993► Subscribe► Subscribe
Pharmacia And Upjohn
PREPIDIL
dinoprostone
GEL;ENDOCERVICAL019617-001Dec 9, 1992► Subscribe► Subscribe
Pharmacia And Upjohn
ZYVOX
linezolid
FOR SUSPENSION;ORAL021132-001Apr 18, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for PHARMACIA drugs

Drugname Dosage Strength Tradename Submissiondate
linezolid
Injection2 mg/mL, 100 mL bag
ZYVOX
12/29/2009
linezolid
Injection2 mg/mL, 300 mL bag
ZYVOX
9/1/2009
linezolid
Oral Suspension100 mg/5 mL
ZYVOX
8/3/2009
tolterodine tartrate
Extended-release Capsules2 mg and 4 mg
DETROL LA
7/30/2007
linezolid
Tablets600 mg
ZYVOX
12/21/2005
colestipol hydrochloride
Tablets1 g
COLESTID
8/23/2005

Non-Orange Book Patents for Pharmacia

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,821,047 Monovalent phage display► Subscribe
6,013,478 Method for identifying active domains and amino acid residues in polypeptides and hormone variants► Subscribe
6,780,613 Growth hormone variants► Subscribe
8,637,646Growth hormone variants► Subscribe
5,955,346 Variants of human prolactin and human placeatal lactogen► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Pharmacia Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)9927983► Subscribe
Australia2001267371► Subscribe
Canada2400118► Subscribe
Japan2006104205► Subscribe
South Korea20070087178► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Pharmacia Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2016 00016Denmark► SubscribePRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
C/GB05/047United Kingdom► SubscribePRODUCT NAME: PEGVISOMANT, OPTIONALLY IN THE FORM OF A PEGYLATION VARIANT; REGISTRATION NO/DATE: EU/1/02/240/001 - 003 20021113
C0005France► SubscribePRODUCT NAME: LINEZOLIDE; NAT. REGISTRATION NO/DATE: NL 26 660 20010831; FIRST REGISTRATION: GB - PL 00 32/0261 20010105
2009004,C0770388Lithuania► SubscribePRODUCT NAME: ESTRADIOLI VALERAS + DIENOGESTUM; NAT. REGISTRATION NO/DATE: LT/1/09/1512/001, 2009 04 06 LT/1/09/1512/002, 2009 04 06 LT/1/09/1512/003 20090406; FIRST REGISTRATION: BE 327792 20081103
1304992/01Switzerland► SubscribePRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Fuji
Cantor Fitzgerald
Chinese Patent Office
McKinsey
Fish and Richardson
Federal Trade Commission
Merck
Argus Health
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot